|
US6391636B1
(en)
|
1994-05-31 |
2002-05-21 |
Isis Pharmaceuticals, Inc. |
Antisense oligonucleotide modulation of raf gene expression
|
|
US6358932B1
(en)
|
1994-05-31 |
2002-03-19 |
Isis Pharmaceticals, Inc. |
Antisense oligonucleotide inhibition of raf gene expression
|
|
US6037136A
(en)
|
1994-10-24 |
2000-03-14 |
Cold Spring Harbor Laboratory |
Interactions between RaF proto-oncogenes and CDC25 phosphatases, and uses related thereto
|
|
US5717100A
(en)
|
1995-10-06 |
1998-02-10 |
Merck & Co., Inc. |
Substituted imidazoles having anti-cancer and cytokine inhibitory activity
|
|
AR012634A1
(es)
|
1997-05-02 |
2000-11-08 |
Sugen Inc |
Compuesto basado en quinazolina, composicion famaceutica que lo comprende, metodo para sintetizarlo, su uso, metodos de modulacion de la funcion deserina/treonina proteinaquinasa con dicho compuesto y metodo in vitro para identificar compuestos que modulan dicha funcion
|
|
US6514977B1
(en)
|
1997-05-22 |
2003-02-04 |
G.D. Searle & Company |
Substituted pyrazoles as p38 kinase inhibitors
|
|
HUP0001880A3
(en)
|
1997-05-22 |
2002-03-28 |
G D Searle & Co Chicago |
Substituted pyrazoles as p38 kinase inhibitors
|
|
GB9716557D0
(en)
|
1997-08-06 |
1997-10-08 |
Glaxo Group Ltd |
Benzylidene-1,3-dihydro-indol-2-one derivatives having anti-cancer activity
|
|
US6022884A
(en)
|
1997-11-07 |
2000-02-08 |
Amgen Inc. |
Substituted pyridine compounds and methods of use
|
|
US6204467B1
(en)
|
1998-03-24 |
2001-03-20 |
Ford Global Technologies, Inc. |
Method and apparatus for resistive welding
|
|
RU2319693C9
(ru)
|
1999-01-13 |
2008-08-20 |
Байер Копэрейшн |
Производные мочевины (варианты), фармацевтическая композиция (варианты) и способ лечения заболевания, связанного с ростом раковых клеток (варианты)
|
|
US6316435B2
(en)
|
1999-02-24 |
2001-11-13 |
Supergen, Inc. |
Combination therapy for lymphoproliferative diseases
|
|
PE20020354A1
(es)
|
2000-09-01 |
2002-06-12 |
Novartis Ag |
Compuestos de hidroxamato como inhibidores de histona-desacetilasa (hda)
|
|
ES2295428T3
(es)
|
2001-10-25 |
2008-04-16 |
Novartis Ag |
Combinaciones que comprenden un inhibidor selectivo de ciclooxigenasa-2.
|
|
JP4399265B2
(ja)
|
2001-12-21 |
2010-01-13 |
ヴァーナリス（ケンブリッジ）リミテッド |
３，４−ジアリールピラゾール、および癌の治療におけるそれらの使用
|
|
EP1682181A2
(en)
|
2003-09-23 |
2006-07-26 |
Novartis AG |
Combination of a vegf receptor inhibitor with a chemotherapeutic agent
|
|
US8969372B2
(en)
|
2003-11-14 |
2015-03-03 |
Aptose Boisciences Inc. |
Aryl imidazoles and their use as anti-cancer agents
|
|
WO2005068452A1
(en)
|
2004-01-09 |
2005-07-28 |
Novartis Ag |
Phenyl-[4-(3-phenyl-1h-pyrazol-4-yl)-pyrimidin-2-yl]-amine derivatives as igf-ir inhibitors
|
|
CN1960988B
(zh)
|
2004-06-10 |
2012-01-25 |
Irm责任有限公司 |
作为蛋白激酶抑制剂的化合物和组合物
|
|
RU2007138264A
(ru)
|
2005-03-17 |
2009-09-10 |
Новартис АГ (CH) |
N-[3-(1-АМИНО-5,6,7,8-ТЕТРАГИДРО-2,4,4b-ТРИАЗАФЛУОРЕН-9-ИЛ)ФЕНИЛ]БЕНЗАМИДЫ В КАЧЕСТВЕ ИНГИБИТОРОВ ТИРОЗИН/ТРЕОНИНКИНАЗ, ПРЕЖДЕ ВСЕГО КИНАЗ В-RAF
|
|
US20070099856A1
(en)
*
|
2005-05-13 |
2007-05-03 |
Gumerlock Paul H |
Combined treatment with docetaxel and an epidermal growth factor receptor kinase inhibitor using an intermittent dosing regimen
|
|
EP1934185A1
(en)
|
2005-08-12 |
2008-06-25 |
Synta Pharmaceuticals Corporation |
Pyrazole compounds that modulate hsp90 activity
|
|
CA2619035A1
(en)
|
2005-08-22 |
2007-03-01 |
Novartis Ag |
Pharmaceutical compositions
|
|
EP1917258A2
(en)
|
2005-08-26 |
2008-05-07 |
SmithKline Beecham Corporation |
Pyrimidinyl-pyrazole inhibitors of aurora kinases
|
|
PE20070427A1
(es)
|
2005-08-30 |
2007-04-21 |
Novartis Ag |
Compuestos derivados de benzimidazoles sustituidos como inhibidores de tirosina quinasas
|
|
EP2024353A2
(en)
|
2006-03-16 |
2009-02-18 |
Pfizer Products Inc. |
Pyrazole compounds
|
|
EP2004165A2
(en)
|
2006-04-05 |
2008-12-24 |
Novartis Pharma AG |
Synergistic combinations of anticancer agents for treating cancer
|
|
US7501430B2
(en)
|
2006-04-17 |
2009-03-10 |
Arqule, Inc. |
RAF inhibitors and their uses
|
|
CN103739595A
(zh)
|
2006-10-02 |
2014-04-23 |
Irm责任有限公司 |
作为蛋白激酶抑制剂的化合物和组合物
|
|
WO2008045627A2
(en)
|
2006-10-06 |
2008-04-17 |
Irm Llc |
Protein kinase inhibitors and methods for using thereof
|
|
US20100069458A1
(en)
|
2007-02-15 |
2010-03-18 |
Peter Wisdom Atadja |
Combination of lbh589 with other therapeutic agents for treating cancer
|
|
US20090022789A1
(en)
|
2007-07-18 |
2009-01-22 |
Supernus Pharmaceuticals, Inc. |
Enhanced formulations of lamotrigine
|
|
CN101815712A
(zh)
|
2007-08-01 |
2010-08-25 |
辉瑞有限公司 |
吡唑化合物及其作为raf抑制剂的用途
|
|
CN101827584A
(zh)
|
2007-10-19 |
2010-09-08 |
雅培股份有限两合公司 |
N-芳基脲基药物的固态分散体产品
|
|
ES2637794T3
(es)
|
2007-11-14 |
2017-10-17 |
Janssen Pharmaceuticals, Inc. |
Derivados de imidazo[1,2-A]piridina y su uso como moduladores alostéricos positivos de receptores MGLUR2
|
|
EA201001456A1
(ru)
|
2008-03-21 |
2011-06-30 |
Новартис Аг |
Новые гетероциклические соединения и их применение
|
|
UA103319C2
(en)
|
2008-05-06 |
2013-10-10 |
Глаксосмитклайн Ллк |
Thiazole- and oxazole-benzene sulfonamide compounds
|
|
AU2009273197B2
(en)
|
2008-07-24 |
2014-01-16 |
Nerviano Medical Sciences S.R.L. |
3,4-diarylpyrazoles as protein kinase inhibitors
|
|
MX2011001090A
(es)
|
2008-07-28 |
2011-03-15 |
Gilead Sciences Inc |
Compuestos de inhibidor de desacetilasa de histona de cicloalquilideno y heterocicloalquilideno.
|
|
MX2011003292A
(es)
|
2008-09-29 |
2011-04-21 |
Boehringer Ingelheim Int |
Compuestos antiproliferativos.
|
|
ES2598178T5
(es)
|
2008-10-07 |
2023-12-26 |
Kudos Pharm Ltd |
Formulación farmacéutica 514
|
|
US20110293750A1
(en)
|
2008-11-11 |
2011-12-01 |
Yale University |
Activated wnt-beta-catenin signaling in melanoma
|
|
ES2422263T3
(es)
|
2008-12-19 |
2013-09-10 |
Nerviano Medical Sciences Srl |
Pirazoles bicíclicos como inhibidores de la proteinquinasa
|
|
AR075180A1
(es)
|
2009-01-29 |
2011-03-16 |
Novartis Ag |
Formulaciones orales solidas de una pirido-pirimidinona
|
|
RU2402602C1
(ru)
|
2009-02-12 |
2010-10-27 |
Государственное учреждение Российский онкологический научный центр им. Н.Н. Блохина РАМН |
КЛЕТОЧНАЯ ЛИНИЯ МЕЛАНОМЫ ЧЕЛОВЕКА mel Rac, ИСПОЛЬЗУЕМАЯ ДЛЯ ПОЛУЧЕНИЯ ПРОТИВООПУХОЛЕВЫХ ВАКЦИН
|
|
WO2010100127A1
(en)
|
2009-03-04 |
2010-09-10 |
Novartis Ag |
Disubstituted imidazole derivatives as modulators of raf kinase
|
|
TWI532484B
(zh)
|
2009-06-08 |
2016-05-11 |
艾伯維有限公司 |
包含凋亡促進劑之固態分散劑
|
|
JP5789602B2
(ja)
|
2009-06-15 |
2015-10-07 |
ネルビアーノ・メデイカル・サイエンシーズ・エツセ・エルレ・エルレ |
置換ピリミジニルピロロピリジノン誘導体、これらの製造のための方法およびキナーゼ阻害剤としてのこれらの使用
|
|
KR101256018B1
(ko)
|
2009-08-20 |
2013-04-18 |
한국과학기술연구원 |
단백질 키나아제 저해활성을 갖는 1,3,6-치환된 인돌 화합물
|
|
JO3002B1
(ar)
|
2009-08-28 |
2016-09-05 |
Irm Llc |
مركبات و تركيبات كمثبطات كيناز بروتين
|
|
US8242260B2
(en)
|
2009-08-28 |
2012-08-14 |
Novartis Ag |
Compounds and compositions as protein kinase inhibitors
|
|
WO2011092088A1
(en)
|
2010-01-27 |
2011-08-04 |
Nerviano Medical Sciences S.R.L. |
Sulfonamido derivatives of 3,4-diarylpyrazoles as protein kinase inhibitors
|
|
EP2560966B1
(en)
|
2010-03-30 |
2021-01-06 |
Verseon International Corporation |
Multisubstituted aromatic compounds as inhibitors of thrombin
|
|
JP5938038B2
(ja)
|
2010-08-03 |
2016-06-22 |
ネルヴィアーノ・メディカル・サイエンシズ・ソチエタ・ア・レスポンサビリタ・リミタータ |
ピラゾロフェニル−ベンゼンスルホンアミド化合物の誘導体及びその抗腫瘍薬としての使用
|
|
HUE032100T2
(en)
|
2011-03-21 |
2017-08-28 |
Valcuria Ab |
A pharmaceutical composition comprising an HDAC inhibitor and a steroid and its use
|
|
US20140113919A1
(en)
|
2011-06-14 |
2014-04-24 |
Novartis Ag |
Combination of panobinostat and ruxolitinib in the treatment of cancer such as a myeloproliferative neoplasm
|
|
DK2782557T3
(en)
|
2011-11-23 |
2018-12-10 |
Array Biopharma Inc |
PHARMACEUTICAL FORMULATIONS
|
|
RU2015121367A
(ru)
|
2012-11-08 |
2017-01-10 |
Новартис Аг |
Фармацевтическая комбинация, содержащая ингибитор b-raf и ингибитор деацетилазы гистонов, и ее применение при лечении пролиферативных заболеваний
|